Thermo Fisher Scientific (NYSE:TMO) reported quarterly earnings results on January 29, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $6.57, beating the consensus estimate of $6.44 by $0.13 per share. Revenue came in at $12.2B, beating the estimate of $11.9B.
Thermo Fisher Scientific's stock moved following the earnings release. The stock currently trades at $576.30 with a market capitalization of $219.4B.


